Mounjaro® 2.5 mg Weight Management Pen

Service Description

Book an appointment for a doctor consultation to assess whether Mounjaro® 2.5 mg is suitable for your weight management needs. Mounjaro® contains tirzepatide, a dual GIP and GLP-1 receptor agonist, and is administered once weekly by subcutaneous injection. The 2.5 mg dose is commonly used as an introductory dose to help the body gradually adapt to the treatment. This appointment may include suitability assessment, dosage guidance, injection instructions and treatment planning by healthcare professionals. A nurse may assist with the first injection if required. Mounjaro® is a prescription medicine and should be used under medical supervision, together with appropriate diet, lifestyle management and regular follow-up. Suitability must be assessed by a doctor before prescription.